
What We're Reading: Faulty Drugs; Biosimilar Awareness; Maine Implements Medicaid
A review of thousands of FDA inspection records, recalls, warning letters, and lawsuits showed how drugs that are poorly manufactured or contaminated can reach patients; biosimilars have the potential to deliver substantial savings to the healthcare system, but only insofar as they are adopted and used in clinical practice; Maine’s new Democratic Governor, Janet Mills, ordered the state to implement Medicaid expansion with an executive order, calling for state health officials to make the necessary changes and work with the Trump administration.
Review of FDA Documents Shows How Faulty Drugs Reach Patients
A review of thousands of FDA inspection records, recalls, warning letters, and lawsuits by
Lack of Awareness of Potential of Biosimilars Hindering Adoption in US, Europe
New Maine Governor Issues Order Implementing Medicaid Expansion
Biosimilars have the potential to deliver substantial savings to the healthcare system, but only insofar as they are adopted and used in clinical practice,
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.